Maiwald Magazine

News and Releases

Maiwald Blog

Revision of G3/04? – Discussion on the continuation of the appeal by intervener

In opposition appeal proceedings "T1286/23.3.2.04", Board 3.2.4 intends to deviate from decision G 3/04 and thus raises the prospect of a corresponding question being referred...

Continue reading

Dr. Michaela Weigel-Krusemarck on current developments in formal priority law

In the course of our regular internal attorney seminar,

Continue reading

One year Unitary Patent and Unified Patent Court in facts and figures

We are already one year into the new European patent and court system – a year of eagerly watching and waiting to see how the Unitary Patent (UP) and the Unified Pa...

Continue reading

查看所有条目

Press Articles

Royalty Pharma and Cytokinetics Announce Expanded Strategic Funding Collaboration Totaling up to $575 Million to Support Commercial Launch of Aficamten and to Advance R&D Pipeline

Deal provides Cytokinetics with diversified access to capital as company advances its specialty cardiology franchise NEW YORK, NY and SOUTH SAN FRANCISCO, CA, May 22, 2024 – Royalty Phar...

Continue reading

Royalty Pharma to Acquire Royalty Interest in Sanofi’s Frexalimab

Frexalimab is in Phase 3 development by Sanofi in multiple sclerosis with multi-blockbuster potential in a wide range of immune-mediated diseases Expands Royalty Pharma’s ...

Continue reading

Royalty Pharma and PureTech Health enter into KarXT Royalty Agreement for up to $500 Million

Royalty Pharma has acquired an interest in PureTech’s royalty in Karuna Therapeutics’ KarXT; Royalty Pharma and PureTech will share in royalties above certain annual sales thresholds

Continue reading

Maiwald in the press

Staff News

Maiwald Congratulates on Passing the EQE Examination

We are very pleased to congratulate 

Continue reading

Maiwald appoints Dr. Michaela Weigel-Krusemarck and Dr. Andreas Eisele as partners

Maiwald, one of Germany's leading intellectual property law firms, has appointed patent attorneys Dr. Mich...

Continue reading

Dr. Kerstin Wolff and Tobias Matschke promoted to Counsel at Maiwald

With effect from July 1, 2024, the law firm of Maiwald, one of Germany's leading intellectual property law firms, has promoted

Continue reading

Staff News

Awards

WirtschaftsWoche 2024: Top law firm & top lawyer

We are delighted that Maiwald has once again been recognized as a “TOP Law Firm 2024” in the field of “Patent Law” by WirtschaftsWoche. In addition, o...

Continue reading

Who´s Who Legal Rankings 2024

We are delighted that our colleagues Dr. Dirk Büh...

Continue reading

IAM Strategy 300: The World’s Leading IP Strategists 2024

This year, IAM again recommends eight of our partners: Dr. Eva Dörner, 

Continue reading

All awards

Events

Maiwald will be represented at WindEnergy Hamburg 2024

WindEnergy Hamburg is much more than just a trade fair. It not only covers the entire wind energy value chain, but also offers special expertise with its focus on storage technologies. It also offers you an extensive program and a lot of added value, such as the synergy with the world's leading trade fair for the maritime industry, SMM, which takes place shortly before Win...

Continue reading

Maiwald is partner of the 3rd Annual Life Science Strategy Summit on IP & Exclusivity from October 8-10 in Munich

We are delighted to support the third annual Life Science Strategy Summit on IP & Exclusivity as a Platinum Partner! This industry-leading life science legal event brings together the leading pharma and biotech experts for three days of practical discussion on the protection of pharm...

Continue reading

Joint symposium with Oblon in Tokyo (9 Oct. 2024) and Osaka (10 Oct. 2024)

The Oblon and Maiwald firms are pleased to invite you to a complimentary joint international symposium on: U.S. and European Patent Practice: Important Aspects for Practitioners to be presented in two convenient locations / dates: ...

Continue reading

Maiwald at the BioM Seminar at Oktober 15 in Martinsried: AI for innovation in the life sciences – opportunities and challenges

The integration of artificial intelligence (AI) into the life sciences is revolutionizing the industry, offering unprecedented opportunities for innovation but also posing significant challenges. Join us for a comprehensive seminar exploring the dynamic intersection of AI and life sciences, with insights from leading experts in the field.

Continue reading

All events